GSA Capital Partners’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-16,096
| Closed | -$304K | – | 1884 |
|
2019
Q3 | $304K | Sell |
16,096
-2,585
| -14% | -$48.8K | 0.04% | 884 |
|
2019
Q2 | $220K | Buy |
18,681
+7,283
| +64% | +$85.8K | 0.02% | 1191 |
|
2019
Q1 | $156K | Buy |
+11,398
| New | +$156K | 0.02% | 1282 |
|
2015
Q4 | – | Sell |
-8,622
| Closed | -$282K | – | 2056 |
|
2015
Q3 | $282K | Buy |
8,622
+2,922
| +51% | +$95.6K | 0.01% | 1401 |
|
2015
Q2 | $302K | Sell |
5,700
-1,580
| -22% | -$83.7K | 0.01% | 1611 |
|
2015
Q1 | $210K | Buy |
+7,280
| New | +$210K | 0.01% | 1907 |
|